{"nct_id":"NCT03035058","title":"Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease","status":"WITHDRAWN","status_verified_date":"2017-03","start_date":"2017-02","start_date_type":null,"primary_completion_date":"2020-09","primary_completion_date_type":"ESTIMATED","completion_date":"2021-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["TAK"]}